Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses What is the best front line treatment for metastatic ?clear cell RCC in 2018? at the Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL September 22, 2018